Unconfigured Ad
Collapse
X
-
For starters, why don't you identify a few reads that are duplicated in the facility-generated BAM, then compare to the same reads in your self-generated BAM? If you have trouble interpreting the results, post the reads here so we can help.
-
Advice on PE ChIP Alignment & Pre-processing Steps??
Hi All
Being a newbie to bioinformatics, once again I am here with what some would find a really silly question but if I don't ask how am I going to learn. So here goes:
We have done some ChIP-Seq experiments. Samples were run on HiSeqV4. We got PE reads. the sequencing facility aligns, process and give us data as cram files. I go from cram to bam using cramtools-3.0. And if I check stats of my bam using bamtools, all samples except input have very high level of duplication (over 80%). If I remove duplicates, I am left with very few reads and hence peak-callers (macs2 & homer) don't return enough peaks.
If I decompress cram to fastq (using cramtools) and then align it myself using bwa mem, I get 0% duplicates. Note that I am aligning to the same reference genome (obtained via cramtools getref ) as the sequencing facility. Using samtools view -H path/to/my/cram/file.cram | grep PG, I figured that the pipeline used to align and process the reads at the sequencing facility uses the same aligner (bwa) but processes the data further with other tools e.g. bamcollate2, bam12auxmerge, bamsormadup, AlignmentFilter, bamstreamingmarkduplicates, etc.
From different ChIP-Seq papers, I have never found the data being processed and filtered so much. My feeling is that these filters and processing might not be required for ChIP-Seq data.
My question is: am I alright to decompress the crams and align myself or is my data not that great after all?
Any tips, tricks, comments, remarks will be highly appreciated!!!
Thanks very much
fh
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 10-22-2026, 11:13 AM
|
0 responses
28 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 11:13 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 10:48 AM
|
0 responses
20 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
38 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
44 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Leave a comment: